200338-34-7

Upstream product

• 200338-29-0 (S)-2-[N-((R)-3-Acetyl-2-oxo-oxazolidine-4-carbonyl)-N'-tert-butoxycarbonyl-hydrazino]-4-[1,3]dioxolan-2-yl-butyric acid methyl ester 
• 200338-27-8 C₂₄H₂₈N₂O₈ 
• 200338-28-9 (S)-2-(N'-tert-Butoxycarbonyl-hydrazino)-4-[1,3]dioxolan-2-yl-butyric acid methyl ester 
• 200338-33-6 (S)-2-((R)-3-Acetyl-2-oxo-oxazolidine-4-carbonyl)-2,3,4,5-tetrahydro-pyridazine-3-carboxylic acid methyl ester 

Downstream Products

• 200338-35-8 (S)-2-((R)-3-tert-Butoxycarbonyl-2-oxo-oxazolidine-4-carbonyl)-2,3,4,5-tetrahydro-pyridazine-3-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Total synthesis of luzopeptin E2

The self-assembly of the 32-membered macrocycle of iuzopeptin E2 (1) has been accomplished by cyclodimerization of a terminally unprotected pentapeptide monomer. This is the key step of the first total synthesis of this macrocyclic antitumor decadepsipept

Elevated conformational rigidity in dipeptides incorporating piperazic acid derivatives

N-Acyl derivatives of piperazic acids display an unusual degree of conformational rigidity. As a consequence, α-N-coupling of a piperazic acid of given configuration (D or L) with an α-aminoacyl unit of opposite configuration (L or D) produces a 'heteroch